13:26 17-09-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug maker Shire rejects offer from AbbVie worth $46 billion

Bishkek (AKIpress) - drugs The Irish pharmaceutical company Shire said on Friday that it had rejected a takeover approach from the American drug maker AbbVie that valued the company at 27.2 billion pounds, or about $46.3 billion, the NY Times said. 

AbbVie, which is based in Chicago, revealed on Friday that it had first approached Shire in early May about a possible tie-up, but was rejected three times by Shire’s board of directors – the latest at the end of May. AbbVie was spun off from Abbott Laboratories last year.

Shire called AbbVie’s proposal “unsolicited and highly conditional” and said that it “fundamentally undervalued the company and its prospects.”

“We believe that Shire has a strong independent future,” Susan Kilsby, the Shire chairwoman, said in a statement.

Under British takeover rules, AbbVie has until July 18 to make a firm offer for Shire or walk away for at least six months before coming back with a further unsolicited offer. After three months, it is possible for the sides to reengage if Shire’s board agrees to it.

“There can be no certainty that any firm offer will be made,” AbbVie said in a statement. “Discussions are no longer ongoing.”

The latest cash and share offer was equal to £46.26 a share, AbbVie said.

Shire’s shares rose 13 percent to £42.26 in trading in London on Friday morning.


Twitterfacebookprint
16:29 20.06.2014
LATEST NEWS
13:21 Kyrgyzstan presents 'El-Sozduk' dictionary mobile app13:15 Ashgabat holds Turkmen-French negotiations13:10 Gazprom to supply up to 100 million cbm of gas to Bishkek combined heat and power plant13:05 Labor Ministry planning expedition to ethnic Kyrgyz in Pamir Mountains12:54 Osh residents complain of higher coal prices, City Council Member says12:45 Typhoon Kalmaegi hits Hainan after slamming Hong Kong12:44 Delegation of Turkmenistan takes part in regional ministerial consultations in Geneva12:39 Hotline for Kazakhstanis launched in China due to typhoon12:20 Turkic speaking countries announce 2015 as Year of Kyrgyzstan's poet Omor Sultanov12:19 More than 200 million people no longer extremely malnourished - FAO12:02 Attraction of residents to protection of state border for fee considered by Parliament11:57 Turkmen President, Iranian Defense Minister discuss cooperation prospects11:52 1% of secured crop areas in Kazakhstan damaged by unfavorable environmental conditions in 2014 – KazAgro11:45 Guardian: Uzbekistan's first daughter 'pictured under house arrest'11:43 Parliament considers amendments to procedure for sending police personnel outside Kyrgyzstan to take part in UN peacekeeping missions11:43 Women's footwear factory to be launched in Kochkor district this September11:33 Kazakhstan and San Marino discuss bilateral cooperation issues11:29 Pilot initiative for TB outpatient treatment within Quality Health Care Project to be considered this week11:21 Kyrgyzstan's economy loses 10% of GDP growth annually due to electricity shortage – expert11:16 Bishkek to host exhibition of Chinese universities
Astana
+21° C
Ashgabat
+34° C
Bishkek
+27° C
Dushanbe
+28° C
Tashkent
+33° C
exchange rates
 
69.72
53.85
8.79
1.39
235.44
181.95
29.61
4.71
6.42
4.99
0.81
0.13
3117.21
2359.56
384.37
62.66
3.69
2.85
0.46
0.07

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75